Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations
- 1 December 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (6) , 1115-1121
- https://doi.org/10.1038/bjc.1993.490
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapyRadiotherapy and Oncology, 1993
- Tumor Radiosensitization by Nicotinamide: A Result of Improved Perfusion and OxygenationRadiation Research, 1989
- Radiosensitization by Nicotinamide in Vivo: A Greater Enhancement of Tumor Damage Compared to That of Normal TissuesRadiation Research, 1987
- Sensitizers and radiation dose fractionation: Results and interpretationsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Skin sensitization by misonidazole: A demonstration of uniform mild hypoxiaBritish Journal of Cancer, 1982
- Reactions to niacinamideJournal of the American Academy of Dermatology, 1981
- Carbogen breathing during radiation therapy The radiation therapy oncology group studyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- A review of hypoxic cell radiosensitization in experimental tumorsPharmacology & Therapeutics, 1979
- Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single dosesInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Megavitamin B-3 Therapy for SchizophreniaCanadian Psychiatric Association Journal, 1971